Cash Cash Equivalents - Resapp Health Ltd (ASX:RAP) - Alpha Spread

First Time Loading...

Watchlist Manager

Watchlist

Price: 0.205 AUD

Updated:

Resapp Health Ltd
Cash & Cash Equivalents

Last Value

3-Years 3-Y CAGR

5-Years 5-Y CAGR

10-Years 10-Y CAGR

Quarterly

Annual

|

Adjust for Inflation

Resapp Health Ltd
Cash & Cash Equivalents Peer Comparison

M7T

4DX

CGS

PME

MDR

Company		Cash & Cash Equivalents	CAGR 3Y	CAGR 5Y	CAGR 10Y
	Resapp Health Ltd ASX:RAP	Cash & Cash Equivalents AU$2.3m	CAGR 3-Years -45%	CAGR 5-Years -23%	CAGR 10-Years 9%
	Mach7 Technologies Ltd ASX:M7T	Cash & Cash Equivalents AU$22.7m	CAGR 3-Years 16%	CAGR 5-Years 48%	CAGR 10-Years 61%
	4DMedical Ltd ASX:4DX	Cash & Cash Equivalents AU$69.6m	CAGR 3-Years 102%	CAGR 5-Years 111%	CAGR 10-Years N/A
	CogState Ltd ASX:CGS	Cash & Cash Equivalents $25.3m	CAGR 3-Years 6%	CAGR 5-Years 44%	CAGR 10-Years 12%
	Pro Medicus Ltd ASX:PME	Cash & Cash Equivalents AU$99.8m	CAGR 3-Years 39%	CAGR 5-Years 47%	CAGR 10-Years 20%
	Medadvisor Ltd ASX:MDR	Cash & Cash Equivalents AU$14.2m	CAGR 3-Years -13%	CAGR 5-Years 14%	CAGR 10-Years 36%

See Also

Based on the financial report for Jun 30, 2022, Resapp Health Ltd's Cash & Cash Equivalents amounts to 2.3m AUD.

Over the last year, the Cash & Cash Equivalents growth was 233%. The average annual Cash & Cash Equivalents growth rates for Resapp Health Ltd have been -45% over the past three years , -23% over the past five years , and 9% over the past ten years .

Join more than 141,900+ value investors using Alpha Spread

Create a free account

or see our plans & pricing

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

What is Intrinsic Value? Help Center Contact Us

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.